Characteristic Cytokine Generation Patterns in Cancer Cells and Infiltrating Lymphocytes in Oral Squamous Cell Carcinomas and the Influence of Chemoradiation Combined with Immunotherapy on These Patterns

Abstract

Objectives: Cytokines produced by tumor cells and tumor-infiltrating lymphocytes (TIL) appear to regulate tumor cell growth and the cytotoxic activity of TIL. The objectives of the present study were to investigate cytokine generation patterns in tumor cells and TIL and to examine the influence of cancer therapy on this cytokine production and the cytotoxic activity of TIL. Methods: We determined the levels of cytokines produced by tumor cells and TIL in vitro and measured the cytotoxic activity of TIL against Daudi cells in patients with oral squamous cell carcinoma (OSC) before and 1 week after the start of concomitant chemo-radio-immunotherapy. Results: Before the therapy, OSC cells generated higher levels of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) than did oral keratinocytes isolated from the noninflamed gingivae of healthy individuals, but both kinds of cells generated similar levels of interleukin (IL)-1β and IL-6. Compared with peripheral blood mononuclear cells (PBMC) of the patients, TIL produced higher levels of IL-1β, IL-6, IL-10, TNF-α and TGF-β, whereas their production of IL-12 and interferon-γ (IFN-γ) was only slightly higher than that in PBMC. After 1 week of therapy, the cytokine production by OSC cells had largely decreased, while the production of TNF-α, IFN-γ, TGF-β and IL-12 by TIL had increased greatly, although other cytokine levels were almost constant during the investigations. The cytotoxic activity of TIL was higher than that of PBMC before the therapy, and this activity was strongly increased by 1 week of therapy. Conclusions: These results suggest that the cytokine productivities of TIL and tumor cells differ from those of PBMC and normal keratinocytes, respectively, and that chemo-radio-immunotherapy modulates in situ cytokine generation, which is advantageous for inhibition of tumor cell growth and activation of TIL.

Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer

“…[21] Cytokines and chemokines within tumors can contribute to the progression of tumors to a more aggressive metastatic phenotype or play a role in tumor therapy. [1722] IL-6 is most often classified as a proinflammatory cytokine, although IL-6 and IL-6 -regulated acute phase proteins were previously suggested as anti-inflammatory and immunosuppressive, and may negatively regulate the acute -phase response 23…”

The pathological significance of Notch1 in oral squamous cell carcinoma

“…In this experiment, TNF-a, a well-known accelerator of tumor invasion, was used. TNF-a has been reported to show an increased expression in OSCC specimens 27 and promote S2 cleavage (resulting in NICD Notch1 in oral squamous cell carcinoma R Yoshida et al production) via TACE maturation in Notch signaling. [28][29][30] As shown in Figure 5, NICD cleavages were observed in a TNF-a concentration-dependent manner.…”

Pattern recognition for predictive, preventive, and personalized medicine in cancer

“…Such integrative approaches include detection of breathprint by electronic nose or integrated analysis of wide range of VOCs detected by gas chromatography/mass spectrometry or related methods [77][78][79]. Apart from VOCs, tumor cells produce wide range of cytokines like IL-4, IL-6, IL-11, IL-15, TNF-a, TGF-b, and others, which activate body's immune system and change the metabolism of wide range of body cells [80,81].…”